Piper Sandler Companies

Fundamentals7.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong cashflow
  • Elevated SG&A
  • Modest leverage

AI
AI Summary

6.0

Piper Sandler's pivot from a cyclical, transaction-driven U.S. ECM trader to a talent- and geography-led advisory/private-capital platform shifts upside toward successful monetization of hires, MENA cross-border deal flow and higher-fee mandates rather than reliance on market rebounds. Investors should monitor revenue conversion versus elevated SG&A and whether FCF buffer is consumed—if hires/acquisitions don't drive fee growth, the current ~19–20x multiple is vulnerable to sharp compression.

AdvisoryPivot
ExecutionRisk
CashBuffer‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Strong cashflow
  • Elevated SG&A
  • Modest leverage

PIPR delivers strong cash generation and high ROE but trades at a premium while elevated SG&A and off‑balance-sheet-like investments raise questions about expense sustainability and liability classification.

CashStrength
HighOpex

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs/lows
  • Buying at support
  • Resistance unmet

Over last month PIPR fell from about $320.73 to $294.27 (~8–9%), carving lower highs/lows with resistance near $320 and support around $279.87–$292.30 — reclaiming $320 would signal a reversal, while a break below ~$280 would likely accelerate downside.

bearish
watch
Support Level: $279.87–$292.30
Resistance Level: $320.73

Stabilized off the $279.87 low with no new lows since 2026-03-12, indicating localized buying interest

Sentiment & News

6.0

Key News Insights:

  • Healthcare hires
  • 4-for-1 split
  • Mixed sentiment

Piper Sandler strengthened its healthcare advisory bench with two senior hires, announced a 4-for-1 stock split, and drew mixed but generally positive analyst and valuation attention.

PIPR
Healthcare

The hires and split improve advisory capacity and share liquidity, likely supporting investor interest and near‑term sentiment despite varied analyst opinions